Vimarsana
Biggest News Aggregation in the World

Ocular Presentation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ocular Presentation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ocular Presentation Today - Breaking & Trending Today

New Investing Ideas in Biotech (NASDAQ: AGLE) (NASDAQ: MRTX) (NASDAQ: SXTP) (NYSE American: AZTR) (NASDAQ: KPRX) (NASDAQ: RSLS) (OTCQB: GENFF) - Vimarsana News

New Investing Ideas in Biotech (NASDAQ: AGLE) (NASDAQ: MRTX) (NASDAQ: SXTP) (NYSE American: AZTR) (NASDAQ: KPRX) (NASDAQ: RSLS) (OTCQB: GENFF)

New Investing Ideas in Biotech (NASDAQ: AGLE) (NASDAQ: MRTX) (NASDAQ: SXTP) (NYSE American: AZTR) (NASDAQ: KPRX) (NASDAQ: RSLS) (OTCQB: GENFF)

Kiora Pharmaceuticals (NASDAQ:KPRX) Stock Price Down 7.5% - Vimarsana News

Kiora Pharmaceuticals (NASDAQ:KPRX) Stock Price Down 7.5%

Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX – Get Rating) shares traded down 7.5% during mid-day trading on Tuesday . The stock traded as low as $0.76 and last traded at $0.78. 726,464 shares changed hands during trading, a decline of 24% from the average session volume of 950,251 shares. The stock had previously closed at $0.84. Analyst […]

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Announces Closing of $6.3 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option - Vimarsana News

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Announces Closing of $6.3 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

Encinitas, California--(Newsfile Corp. - June 6, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced the closing of an underwritten public offering for gross

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Announces Pricing of $5.5 Million Underwritten Public Offering - Vimarsana News

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Announces Pricing of $5.5 Million Underwritten Public Offering

Encinitas, California--(Newsfile Corp. - June 2, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced the pricing of an underwritten public offering for gross

Short Interest in Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) Expands By 13.4% - Vimarsana News

Short Interest in Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) Expands By 13.4%

Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX – Get Rating) was the recipient of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 91,400 shares, an increase of 13.4% from the April 15th total of 80,600 shares. Currently, 5.4% of the shares of the company are short […]